ASH 51st (2009)

Title Content type
Pretransplant Factors That Influence Intravenous Busulfan Kinetics in Adult Patients. (click for details)
Low Sensitivity of the (1-3)-Beta-D-Glucan Assay for Diagnosis of Invasive Aspergillosis in Hematologic Malignancy Patients. (click for details)
Empiric Antifungal Therapy with Amphotericin B in the Era of Fluconazole Prophylaxis: a Cohort Study in Adults with Acute Myeloid Leukemia Treated within An Institutional Antifungal Policy. (click for details)
Monitoring Trough Concentration of Voriconazole Is Important to Ensure Successful Antifungal Therapy and to Avoid Hepatic Damage in Patients with Hematological Disorders. (click for details)
The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography and CT (PET-CT) for the Diagnosis of Infections in Hemato-Oncological Patients with Persistent Neutropenia and Fever. (click for details)
Adoptive Immunotherapy with Tregs Prevents GvHD and Favours Immune Reconstitution After HLA Haploidentical Transplants for Hematological Malignancies. (click for details)
Selecting Haploidentical Transplant Donors for Deploying Optimal NK Cell Allotherapy. (click for details)
Clinical Efficacy and Tolerability of Granulocyte Transfusions for the Treatment of Febrile Neutropenia in the Patients with Hematologic Malignancies. (click for details)
Chemoimmuno-Therapy with Fludarabine, Cyclophosphamide and Alemtuzumab (FC-Cam) in Patients with Relapsed or Genetic High-Risk CLL: Final Analysis of the CLL2L Trial of the German CLL Study Group. (click for details)
Elevated Serum Hepcidin in Patients with AML Prior to and After Allogeneic Hematopoietic Cell Transplantation Does Not Correlate with Transfusional Body Iron, HFE Genotype or Graft Versus Host Disease and May Protect From Excessive Parenchymal Iron Loadin (click for details)

Pages

Subscribe to ASH 51st (2009)